AI assistant
Lexaria Bioscience Corp. — Director's Dealing 2014
Jan 17, 2014
34983_dirs_2014-01-17_c6ec8148-3719-4fe3-98ca-0216b0babb96.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2008-07-30
Reporting Person: BUNKA CHRISTOPHER (Director, Chairman, President & CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-07-29 | Common Shares | P | 12000 | $0.35 | Acquired | 2086950 | Indirect |
| 2008-07-30 | Common Shares | P | 9500 | $0.35 | Acquired | 2096450 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 800000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options | $0.8 | 2011-04-26 | Common Shares (400000) | 400000 | Direct |
| Warrants | $0.6 | 2009-11-09 | Common Shares (1166800) | 1166800 | Indirect |
Footnotes
F1: Private Holding Company, C.A.B. Financial Services Ltd., is wholly owned by C. Bunka.
F2: This total was incorrectly understated by 1,000 shares on original filing, resulting in subsequent filing errors in total holdings of same amount, until 4 to 1 conversion at which time, total Indirect holdings were then understated by 250 shares. The correct holdings will be reflected on this amendment and again on January 17, 2014 Form 4A and in all future filings.
F3: This total includes the 800,000 common shares owned Directly.
F4: On June 19, 2007, the exercise price was reduced from $1.30.